Envoy Medical, Inc. (COCHW) shareholders
COCHWNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCH
$0.03−0.00 (-15.49%)
Close on Oct 30, 2026Market cap $511.80MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
5M
Shares held, 13F filers
Institutional holders
32
0 new, 2 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
6 buys · 0 sales
Net bought $8.17M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Glen A. Taylor | 68,909,614 | 84.80% | 13D (active) amendment | Feb 12, 2026 |
| Bleichroeder Holdings LLC Joint filing with Bleichroeder LP (9.99%), Andrew Gundlach (9.99%) | 7,839,000 | 9.99% | 13G (passive) | Mar 31, 2026 |
| Nantahala Capital Management, LLC Joint filing with Wilmot B. Harkey (9.99%), Daniel Mack (9.99%) | 7,683,798 | 9.99% | 13G (passive) | Mar 31, 2026 |
| Anzu SPAC GP I LLC | 2,718,841 | 11.33% | 13D (active) | Sep 29, 2023 |
| Waqas Khatri Joint filing with Ayrton Capital LLC (7.87%), Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (7.87%) | 2,457,963 | 7.87% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of COCHW | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Aristeia Capital LLC | 1,143,978 | – | $54.23K | – | 0.00% |
| Toronto Dominion Bank | 534,600 | – | $26.73K | −128 | 0.00% |
| Clear Street Group Inc. | 301,016 | – | $14.99K | – | 0.00% |
| Polar Asset Management Partners Inc. | 297,100 | – | $14.08K | – | 0.00% |
| Bnp Paribas Arbitrage, Snc | 283,333 | – | $14.11K | – | 0.00% |
| Bracebridge Capital, LLC | 262,156 | – | $13.06K | – | 0.00% |
| Diametric Capital, LP | 236,254 | – | $11.77K | – | 0.00% |
| SummitTX Capital, L.P. | 222,671 | – | $10.02K | −20,703 | 0.00% |
| Jane Street Group, LLC | 208,166 | – | $10.37K | – | 0.00% |
| Sculptor Capital LP | 182,142 | – | $9.07K | – | 0.00% |
| Whitebox Advisors LLC | 174,000 | – | $8.67K | – | 0.00% |
| Vestcor Inc | 166,666 | – | $7.00K | – | 0.00% |
| Moore Capital Management, LP | 166,666 | – | $8.30K | – | 0.00% |
| Q Global Advisors, LLC | 129,120 | – | $6.00K | – | 0.00% |
| Goldman Sachs Group Inc | 125,039 | – | $6.23K | – | 0.00% |
| D. E. Shaw & Co., Inc. | 113,431 | – | $5.10K | – | 0.00% |
| Calamos Advisors LLC | 100,000 | – | $4.50K | – | 0.00% |
| Dupont Capital Management Corp | 100,000 | – | $4.50K | – | 0.21% |
| Oasis Management Co Ltd. | 100,000 | – | $79.20K | – | 0.00% |
| Silver Rock Financial LP | 81,975 | – | $4.08K | – | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 32 | 5M | 0 / 0 | 2 / 2 | 0M | 0M |
| Q1 2026 | 34 | 5M | 2 / 2 | 4 / 2 | 0M | 0M |
| Q4 2025 | 35 | 6M | 2 / 2 | 5 / 3 | 0M | 0M |
| Q3 2025 | 36 | 6M | 5 / 0 | 3 / 2 | 1M | 0M |
| Q2 2025 | 35 | 6M | 2 / 0 | 2 / 2 | 1M | 0M |
| Q1 2025 | 36 | 6M | 0 / 1 | 2 / 2 | 0M | 1M |
| Q4 2024 | 39 | 7M | 1 / 2 | 5 / 3 | 1M | 1M |
| Q3 2024 | 41 | 7M | 1 / 1 | 2 / 5 | 0M | 0M |
| Q2 2024 | 45 | 7M | 2 / 2 | 9 / 3 | 0M | 1M |
| Q1 2024 | 47 | 8M | 5 / 6 | 8 / 10 | 2M | 2M |
| Q4 2023 | 53 | 8M | 51 / 0 | 1 / 0 | 7M | 0M |
| Q3 2023 | 2 | 1M | 2 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of COCHW | Value | % of fund | As of |
|---|---|---|---|---|---|
| Calamos Market Neutral Income Fund | 100,000 | – | $3.45K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Brent T. Lucas | Chief Executive Officer, Director | 342,666 | Jun 23, 2026 |
| Robert Potashnick | CAO & VP of Finance | 212,500 | Aug 26, 2026 |
| Chas McKhann | Director | – | Apr 17, 2026 |
| Charles Brynelsen | Director | 1,050,000 | Feb 17, 2026 |
| Mona Chetan Patel | Director | 332,500 | Feb 17, 2026 |
| Susan Kantor | Director | 174,037 | Feb 17, 2026 |
| Michael Curtis Crowe | Director | – | Dec 5, 2025 |
| Janis Smith-Gomez | Director | – | Dec 5, 2025 |
| Glen A. Taylor | 10% owner | 29,040,049 | Feb 17, 2026 |
| SPAC GP I. LLC Anzu | 10% owner | 2,490,000 | Dec 26, 2024 |
| Whitney Haring-Smith | 10% owner | 11,500,000 | Dec 26, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Brent T. Lucas Chief Executive Officer, Director | May 29, 2026 | Award | +32,856 | $0.60 | $19.71K | 329,946 |
| Charles Brynelsen Director | Feb 12, 2026 | Buy | +1,000,000 | $0.40 | $400.00K | 1,050,000 |
| Susan Kantor Director | Feb 12, 2026 | Buy | +96,150 | $0.40 | $38.46K | 174,037 |
| Mona Chetan Patel Director | Feb 12, 2026 | Buy | +312,500 | $0.40 | $125.00K | 332,500 |
| Brent T. Lucas Chief Executive Officer, Director | Feb 12, 2026 | Buy | +62,500 | $0.40 | $25.00K | 297,090 |
| Robert Potashnick Interim CFO | Feb 12, 2026 | Buy | +212,500 | $0.40 | $85.00K | 212,500 |
| Glen A. Taylor 10% owner | Feb 12, 2026 | Buy | +18,750,000 | $0.40 | $7.50M | 21,703,607 |
| Brent T. Lucas Chief Executive Officer, Director | Nov 28, 2025 | Award | +18,105 | $0.71 | $12.85K | 234,590 |
| Mona Chetan Patel Director | Jun 11, 2025 | Buy | +2,500 | $1.47 | $3.68K | 20,000 |
| Mona Chetan Patel Director | Jun 6, 2025 | Buy | +10,000 | $1.46 | $14.60K | 17,500 |
| Brent T. Lucas Chief Executive Officer, Director | May 30, 2025 | Award | +7,742 | $1.29 | $9.99K | 216,485 |
| Charles Brynelsen Director | May 27, 2025 | Buy | +35,000 | $1.65 | $57.75K | 50,000 |
| Charles Brynelsen Director | May 23, 2025 | Buy | +13,000 | $1.64 | $21.32K | 15,000 |
| Charles Brynelsen Director | May 22, 2025 | Buy | +2,000 | $1.68 | $3.36K | 2,000 |
| Susan Kantor Director | Dec 23, 2024 | Other | +34,705 | – | – | 77,887 |
| SPAC GP I. LLC Anzu 10% owner | Dec 23, 2024 | Other | −2,028,986 | – | – | 0 |
| SPAC GP I. LLC Anzu 10% owner | Dec 20, 2024 | Conversion | +1,028,986 | – | – | 2,028,986 |
| Brent T. Lucas Chief Executive Officer, Director | Nov 30, 2024 | Award | +5,165 | $1.94 | $10.02K | 208,743 |
| Mona Chetan Patel Director | Nov 20, 2024 | Buy | +2,500 | $2.28 | $5.70K | 7,500 |
| Whitney Haring-Smith 10% owner | Nov 19, 2024 | Other | −1,000,000 | – | – | 1,000,000 |
| Susan Kantor Director | Nov 19, 2024 | Other | +18,182 | – | – | 43,182 |
| Mona Chetan Patel Director | Sep 11, 2024 | Buy | +4,000 | $3.33 | $13.32K | 5,000 |
| Mona Chetan Patel Director | Sep 9, 2024 | Buy | +1,000 | $3.20 | $3.20K | 1,000 |
| Brent T. Lucas Chief Executive Officer, Director | Jun 24, 2024 | Other | +10,176 | – | – | 12,720 |
| Brent T. Lucas Chief Executive Officer, Director | Jun 24, 2024 | Other | +74,784 | – | – | 195,615 |
| Brent T. Lucas Chief Executive Officer, Director | Nov 21, 2023 | Buy | +2,380 | $0.92 | $2.19K | 120,831 |
| Brent T. Lucas Chief Executive Officer, Director | Nov 21, 2023 | Buy | +10,000 | $0.98 | $9.80K | 118,451 |
| Diane L. Dewbrey Director | Sep 29, 2023 | Conversion | +25,000 | – | – | 25,000 |
| Priya Cherian Huskins Director | Sep 29, 2023 | Conversion | +25,000 | – | – | 25,000 |
| Daniel J. Hirsch CFO and Corporate Secretary, Director | Sep 29, 2023 | Conversion | +25,000 | – | – | 25,000 |
| SPAC GP I. LLC Anzu 10% owner | Sep 29, 2023 | Conversion | +2,490,000 | – | – | 2,490,000 |
| SPAC GP I. LLC Anzu 10% owner | Sep 29, 2023 | Other | −490,000 | – | – | 2,000,000 |
| Susan Kantor Director | Sep 29, 2023 | Conversion | +25,000 | – | – | 25,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 15, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+308.3%
From 0M shares
Short volume, 20 days
46.2%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Envoy Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 9,388 shares on Sep 15, 2026 over the last 90 days.